Extended 10-Panel
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
A cannabinoids/THC urine test is a qualitative screening that detects the presence of THC metabolites in urine. THC (delta-9-tetrahydrocannabinol) is the primary psychoactive compound in cannabis.
Doctor's Assessment Included
This test detects the presence of THC-COOH (11-nor-9-carboxy-THC), the primary urinary metabolite of THC. After cannabis use, THC is metabolised in the liver and its metabolites are excreted in urine over an extended period. The test provides a qualitative result indicating whether THC metabolites are present above the assay cut-off level.
THC metabolites are lipophilic and accumulate in fatty tissue, which contributes to the potentially long detection window, particularly with regular use.
THC testing is one of the most commonly performed drug screenings and is a standard component of workplace, clinical, and forensic drug testing panels. Detection indicates cannabis exposure within the relevant detection window.
Interpretation should consider frequency of use, as single-use and chronic use produce very different detection windows. Clinical context is important for appropriate assessment of results.
Testing may be relevant as part of standard workplace drug screening, pre-employment testing, clinical assessments, substance abuse treatment monitoring, or legal and forensic evaluations.
Consult a healthcare professional for guidance on interpretation, particularly given the wide variation in detection windows based on usage patterns.
These panels measure values from the same category as this marker.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
CDT biomarker test designed to indicate chronic alcohol consumption patterns.
Individual cocaine metabolite screening with laboratory confirmation.
Cannabinoids (THC)
€199,-